276 related articles for article (PubMed ID: 232147)
1. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
Singh A; Usher M
J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
7. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
8. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
Malin FR; Rollo FD; Gertz EW
J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
[TBL] [Abstract][Full Text] [Related]
9. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
Rudd TG; Allen DR; Hartnett DE
J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
Bell D; Millar AM; Grayshan R; Muir AL
Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
[No Abstract] [Full Text] [Related]
12. The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication.
Botvinick EH; Shames DM; Sharpe DN; Klausner SC; Werner JA; Chatterjee K; Parmley WW
J Nucl Med; 1978 Oct; 19(10):1121-5. PubMed ID: 214527
[TBL] [Abstract][Full Text] [Related]
13. Comparison of left ventricular function and infarct size in patients with and without persistently positive technetium-99m pyrophosphate myocardial scintigrams after myocardial infarction: analysis of 357 patients.
Croft CH; Rude RE; Lewis SE; Parkey RW; Poole WK; Parker C; Fox N; Roberts R; Strauss HW; Thomas LJ
Am J Cardiol; 1984 Feb; 53(4):421-8. PubMed ID: 6320623
[TBL] [Abstract][Full Text] [Related]
14. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
Logic JR; Meyer-Pavel CM; Blackman J
J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
[No Abstract] [Full Text] [Related]
16. [Bayesian analysis of myocardial scintigraphy using 99mTc-Sn(II)-methylenediphosphonate and using 99mTc-Sn(II)-pyrophosphate].
Cuarón A; Acero A; Cárdenas M
Arch Inst Cardiol Mex; 1982; 52(5):365-72. PubMed ID: 7149857
[TBL] [Abstract][Full Text] [Related]
17. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
18. Detection of acute myocardial infarction by pyrophosphate 99m Tc scintigraphy.
Lyons KP; Olson H
Conn Med; 1982 Apr; 46(4):191. PubMed ID: 6286244
[No Abstract] [Full Text] [Related]
19. Sensitivity and specificity of Tc-99m-pyrophosphate myocardial scintigraphy for the detection of acute myocardial infarction.
Lyons KP; Olson HG; Aronow WS
Clin Nucl Med; 1980 Jan; 5(1):8-12. PubMed ID: 6243524
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of persistently positive technetium-99m pyrophosphate myocardial scintigrams in patients with acute myocardial infarction].
Nakashima Y; Fukuzaki H; Maeda K; Minamiji K; Kida T; Yoshida Y
Kaku Igaku; 1984 Mar; 21(3):221-9. PubMed ID: 6088866
[No Abstract] [Full Text] [Related]
[Next] [New Search]